Samrat Pharmachem share news, announcements and annual reports
BSE: 530125Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹271.35.
30 Oct: open ₹272.00, high ₹272.00, low ₹261.00
- Under BSE's long-term additional surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 14 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹81 Cr3,210th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.16
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 683
Samrat Pharmachem share news and announcements
395 announcements, routine notices left out, newest first. Page 4 of 8.
Nov 2021
Oct 2021
13 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 04 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2021
28 Sep · Board meeting
Meeting on 13 Nov 2021: quarterly results
Aug 2021
Jul 2021
19 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 06 Jul · Board meeting
Meeting on 13 Aug 2021: quarterly results6 Jul · Disclosure On Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirement), Regulation 2015 For The Half Year Ended 31St March, 2021
Jun 2021
7 Jun · Board meeting
Meeting on 30 Jun 2021: audited results
Apr 2021
27 Apr · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on April 27, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant ....15 Apr · Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended March 31, 2021
15 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 015 Apr · Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
14 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....
Feb 2021
Jan 2021
20 Jan · Disclosure On Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirement), Regulation 2015 For The Half Year Ended 30Th September, 2020
19 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....19 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 013 Jan · Board meeting
Meeting on 13 Feb 2021: quarterly results
Dec 2020
31 Dec · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....7 Dec · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on December 7, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....4 Dec · Reg. 34 (1) Annual Report
Nov 2020
Oct 2020
27 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....21 Oct · Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
20 Oct · Board meeting
Meeting on 13 Nov 2020: quarterly results20 Oct · Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended September 30, 2020
20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0